Clinical and genetic characteristics in patients with Huntington's Disease from Argentina

Emilia Gatto1, Virginia Parisi, Gabriel Persi

  • 1Department of Movement Disorders, Instituto Neurociencias de Buenos Aires (INEBA), Buenos Aires, Argentina. emiliagatto@fibertel.com.ar

Insights

This study presents the first demographic, clinical, and molecular data for Huntington

Area of Science:

  • Neurogenetics
  • Neurology
  • Human Genetics

Background:

  • Huntington's Disease (HD) is a neurodegenerative disorder caused by an unstable CAG repeat expansion in the HTT gene.
  • Limited data exists regarding the prevalence and characteristics of HD in Argentina.

Purpose of the Study:

  • To characterize the demographic, clinical, and molecular profiles of Huntington's Disease patients in Argentina.
  • To establish a baseline understanding of HD in a previously underrepresented population.

Main Methods:

  • Recruitment of 59 Huntington's Disease patients from a single department.
  • Inclusion of comprehensive patient interviews, neurological examinations, and genetic analysis.
  • Statistical analysis utilizing G-Stat 2.0 and non-parametric Wilcoxon tests.

Main Results:

  • A cohort of 32 women and 27 men with a mean age of 45.7 years and mean age at onset of 35.8 years.
  • No significant gender prevalence observed; inverse correlation between CAG repeat size and age at onset (r=-0.58, p=0.0008).
  • Higher incidence of juvenile Huntington's Disease (16.6%) than previously reported; mean CAG repeat of 45.1 in affected alleles.

Conclusions:

  • This study provides the first comprehensive dataset for Argentinean Huntington's Disease patients.
  • Demographic, clinical, and molecular findings are comparable to those reported in Western European populations.
  • Highlights the need for further research and clinical attention to HD in Argentina.
Abstract

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Genetic Lingo01:11

Genetic Lingo

Overview
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...